Stock listing
Clinical Laserthermia Systems Ab Class B
Selected listing: LS60 · FWB · EUR · DE
Clinical Laserthermia Systems Ab Class B (Frankfurt:LS60), Health Technology. Latest release May 28, 2026: CLS Enters Research Agreement With U.S. National…
- Ticker
- Frankfurt:LS60
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Frankfurt
- Currency
- EUR
About Clinical Laserthermia Systems Ab Class B
The company specializes in innovative laser therapy solutions for medical applications. Its focus is on advancing treatment options in the healthcare sector.
Latest news from Clinical Laserthermia Systems Ab Class B
CLS Enters Research Agreement With U.S. National Cancer Institute
May 28, 2026
Sweden's CLS Q1 sales fall 72% after partner talks
May 12, 2026
CLS Receives Order Worth SEK 23 Mln For Prism Business
May 11, 2026
Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026
February 20, 2026
CLS Initiates Recruitment Process For Permanent Chief Financial Officer
December 12, 2025
Research Clinical Laserthermia Systems Ab Class B
Clinical Laserthermia Systems Ab Class B company profile
View the public company page for Clinical Laserthermia Systems Ab Class B on 6ix.
Clinical Laserthermia Systems Ab Class B news
Read company news and market updates connected to Clinical Laserthermia Systems Ab Class B.
Clinical Laserthermia Systems Ab Class B investor events
Find investor webinars, events, and replay context for Clinical Laserthermia Systems Ab Class B.